This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.The UH CRC program has expanded to include a HIV Research Core in affiliation with the Hawaii AIDS Clinical Research Program (HACRP) of the UH John A. Burns School of Medicine. Located at Leahi Hospital, the HACRP emphasizes HIV education, research, and service in accordance with the following specific aims:1) To develop clinical research capabilities to evaluate optimal therapies for HIV-1 infection and AIDS-associated complications.2) To provide access to clinical research, trials, and studies for all HIV-1 infected patients in Hawaii.3) To facilitate the transfer of research findings to clinical care which will ultimately improve the quality of life for patients with HIV-1 infection. THe HACRP also includes the Hawaii AIDS Clinical Trials Unit (HACTU) and the NeuroAIDS Specialized Neuroscience Research Program (NeuroAIDS SNRP). This affiliation with the HACRP is in congruence with the specific aims of the UH CRC program, namely, to build and refine clinical excellence and expertise in Early Human Development, Bionutrition, HIV and Cancer, with particular emphasis on issues of clinical relevance to the populations of the State of Hawaii. Moreover, the development of the HIV Research Core with the HACRP gives evidence of research collaboration and partnership which will further strengthen the University of Hawaii's ability to compete for a NIH institutional Clinical Translational Science Award (CTSA).

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR011091-14
Application #
7725326
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2008-07-01
Project End
2009-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
14
Fiscal Year
2008
Total Cost
$178,065
Indirect Cost
Name
University of Hawaii
Department
Type
Organized Research Units
DUNS #
965088057
City
Honolulu
State
HI
Country
United States
Zip Code
96822
Petrov, Andrii Y; Herbst, Michael; Andrew Stenger, V (2017) Improving temporal resolution in fMRI using a 3D spiral acquisition and low rank plus sparse (L+S) reconstruction. Neuroimage 157:660-674
Foli, Karen J; Hebdon, Megan; Lim, Eunjung et al. (2017) Transitions of Adoptive Parents: A Longitudinal Mixed Methods Analysis. Arch Psychiatr Nurs 31:483-492
Chuang, Eleanore; Lim, Eunjung; Milne, Cris et al. (2016) Human Papillomavirus at Multiple Sites Associated with Anal Squamous Intraepithelial Lesions in HIV-Seropositive Individuals. Ann Clin Cytol Pathol 2:
Deng, Weiran; Zahneisen, Benjamin; Stenger, V Andrew (2016) Rotated stack-of-spirals partial acquisition for rapid volumetric parallel MRI. Magn Reson Med 76:127-35
Garcia, Alan F; Yamaga, Karen M; Shafer, Leigh Anne et al. (2016) Cardiac Myosin Epitopes Recognized by Autoantibody in Acute and Convalescent Rheumatic Fever. Pediatr Infect Dis J 35:1021-6
Steinemann, Susan; Kurosawa, Gene; Wei, Alexander et al. (2016) Role confusion and self-assessment in interprofessional trauma teams. Am J Surg 211:482-8
Yamasato, Kelly; Kaneshiro, Bliss; Salcedo, Jennifer (2015) Neuraxial blockade for external cephalic version: Cost analysis. J Obstet Gynaecol Res 41:1023-31
Pokhrel, Pallav; Fagan, Pebbles; Kehl, Lisa et al. (2015) Receptivity to e-cigarette marketing, harm perceptions, and e-cigarette use. Am J Health Behav 39:121-31
Smith, Lynne M; Diaz, Sabrina; LaGasse, Linda L et al. (2015) Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study. Neurotoxicol Teratol 51:35-44
Shikuma, Cecilia M; Bennett, Kara; Ananworanich, Jintanat et al. (2015) Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy. J Neurovirol 21:525-34

Showing the most recent 10 out of 245 publications